Since inhibition of Nrp1-dependent pathways has been reported to affect the growth of glioma-derived tumor cell lines [7, 20], we investigated the capacity of increasing amounts of EG00229 to suppress growth and migratory behavior of the GL261-eGFP cell line in vitro. The gene discussed is NRP1; the disease is neoplasm.